An analysis of trends and growth factor receptor expression of GI carcinoid tumors - Wikidata - wikimedia - TriplyDB

An analysis of trends and growth factor receptor expression of GI carcinoid tumors

An analysis of trends and growth factor receptor expression of GI carcinoid tumors

http://www.wikidata.org/entity/Q33985773

about

Targeting the mTOR signaling pathway in neuroendocrine tumors Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors.VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis.The effect of PTEN on serotonin synthesis and secretion from the carcinoid cell line BON New pharmacologic therapies for gastroenteropancreatic neuroendocrine tumors Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors.Can insulin-like growth factor 1 (IGF-1), IGF-1 receptor connective tissue growth factor and Ki-67 labelling index have a prognostic role in pulmonary carcinoids?

P2860

Q26852089-6EB4E62F-9B35-4DFE-9735-48897E02B738 Q33406354-0CA23E00-530C-4076-AF94-6D0AA9F79618 Q33926020-A4238637-4DF9-4529-9A6A-8E36A05A5092 Q35178600-9DE4F866-1027-4D43-ADF0-8593C4FBA963 Q36790050-B094B8C3-B769-4AE3-9657-2D282A7A0F00 Q36813981-85AE3104-5656-49D7-B1C9-8B52DB1E2015 Q55035206-31B98156-4A91-452E-BA12-B1DDBAF9892C

P2860

An analysis of trends and growth factor receptor expression of GI carcinoid tumors

http://www.wikidata.org/entity/Q33985773

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

An analysis of trends and growth factor receptor expression of GI carcinoid tumors

@ast

An analysis of trends and growth factor receptor expression of GI carcinoid tumors

@en

type

label

An analysis of trends and growth factor receptor expression of GI carcinoid tumors

@ast

An analysis of trends and growth factor receptor expression of GI carcinoid tumors

@en

prefLabel

An analysis of trends and growth factor receptor expression of GI carcinoid tumors

@ast

An analysis of trends and growth factor receptor expression of GI carcinoid tumors

@en

P1433

Q33985773-ADE3716D-550B-4031-8C03-CCA5A1B8FD86

P1476

Q33985773-8FECBA46-6356-4E64-8EFD-E99F6DDB8E4B

P2093

Q33985773-1066A857-097B-4128-B552-516DB0FD617C

Q33985773-2B313109-95E7-42F8-9655-1E4D2856A444

Q33985773-30C93C51-0462-455A-868F-B1F9FC92DE0A

Q33985773-5F1AD6F1-2E60-42BD-9D8D-8750726D4DC1

Q33985773-5FC9358A-9ADE-4309-A6E8-3A43C975E932

Q33985773-6C7061F1-36AE-47DF-9372-DD9CBE129E2A

Q33985773-94ACCE82-23B2-4AA9-B289-6C1308F05D83

Q33985773-DEECCAA1-9C39-41AB-B249-47EA0FB81D51

Q33985773-EAE3FB9B-B919-400B-B6FB-AE494F088B21

P2860

Q33985773-12171C43-47D4-4A8E-A6B3-FC6403DB75CA

Q33985773-1501CDBD-C508-4E33-A8F7-4B3A878358E1

Q33985773-1978EFB4-6ACF-4006-A662-D4EA1D64694C

Q33985773-1A1674A3-6A7E-4516-AA73-9A7D77612D62

Q33985773-1FB68442-E3CA-4119-9A8A-18387F38D477

Q33985773-24072069-A21A-482D-A820-4F00C7539B11

Q33985773-4063D6FF-C3A8-486F-BDD2-AD9816B7D09C

Q33985773-40F10134-3C25-45FA-8256-20ED7482A5F2

Q33985773-4C0185BD-8F1A-44CD-A67B-25FF5541C339

Q33985773-53C62AFF-125C-44DE-BA65-D7BAB30FA225

P2888

Q33985773-CA3C4712-1D8C-4347-90DD-A7D615CA9E7B

P304

Q33985773-CF8D955E-81BF-4E34-A44D-DD7C83F4A4F2

P31

Q33985773-00041E18-EABC-4DC9-85D7-498CCF11E734

P356

Q33985773-D3D080AE-4101-4909-8DCD-2A36036A6FE0

P433

Q33985773-16D8F33D-2E0B-4C94-B330-63AAD6D49FA2

P478

Q33985773-9CB877D4-B42D-4425-A911-2164D662E98E

P577

Q33985773-91D7028A-1A13-4319-B1FE-CA4A56CAF802

P5875

Q33985773-C064C7C4-AA18-429B-A228-B2BC7D2659D3

P698

Q33985773-5DBF5808-CAF2-4DCE-8A85-B73D178C3E6D

P932

Q33985773-157858F9-38E3-4ECC-9A77-6B9700ABD5B3

P356

S11605-009-0958-8

P1433

Journal of Gastrointestinal Surgery

P1476

An analysis of trends and growth factor receptor expression of GI carcinoid tumors

@en

P2093

B Mark Evers

http://www.w3.org/2001/XMLSchema#string

Hung Q Doan

http://www.w3.org/2001/XMLSchema#string

Jessica N Johnson

http://www.w3.org/2001/XMLSchema#string

Kanika A Bowen

http://www.w3.org/2001/XMLSchema#string

Lindsey N Jackson

http://www.w3.org/2001/XMLSchema#string

Pat Gulhati

http://www.w3.org/2001/XMLSchema#string

Scott R Silva

http://www.w3.org/2001/XMLSchema#string

Suimin Qiu

http://www.w3.org/2001/XMLSchema#string

Taylor S Riall

http://www.w3.org/2001/XMLSchema#string

P2860

Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1)

Carcinoid tumors

A comprehensive pathway map of epidermal growth factor receptor signaling

ErbB receptors: from oncogenes to targeted cancer therapies

Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu.

Untangling the ErbB signalling network

The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy

Gastroenteropancreatic neuroendocrine tumours

Bronchopulmonary neuroendocrine tumors

Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells

P2888

s11605-009-0958-8

P304

1773-1780

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11605-009-0958-8

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26652273

http://www.w3.org/2001/XMLSchema#string

P698

19582519

http://www.w3.org/2001/XMLSchema#string

P932

2902268

http://www.w3.org/2001/XMLSchema#string